CATX
Perspective Therapeutics Inc.
2.50$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Perspective Therapeutics Inc. (CATX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -82 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2010 | 2011 | 2011 | 2012 | 2012 | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.7 | -2.7 | -2.4 | -2.4 | -2.4 | -2.4 | -3.1 | -3.1 | -3.2 | -3.2 | -3.5 | -3.5 | -3.9 | -3.9 | -5.7 | -5.7 | -5.7 | -5.0 | -5.0 | -3.6 | -3.6 | -2.8 | -2.8 | -7.7 | -7.7 | -10 | -12 | -37 | -18 | -82 | |
| 1.0 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | 0.5 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 1.0 | 2.3 | 3.3 | |
| 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 1.1 | 1.1 | 0.8 | 1.3 | 3.7 | 5.4 | 9.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4 | – | 0.4 | – | 1.1 | – | – | – | – | – | |
| 0.0 | 0.0 | -0.7 | -0.7 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.4 | -0.4 | -0.4 | 0.4 | 0.4 | 0.0 | 0.0 | 0.2 | -0.5 | -0.5 | -0.8 | -0.8 | -0.1 | -0.1 | -1.9 | -1.9 | -1.7 | 0.3 | 2.9 | 32 | 1.7 | |
| 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 1.1 | 54 | 13 | |
| – | 1.6 | – | -0.2 | – | -0.1 | – | 0.0 | – | -15 | – | 0.8 | – | 8.8 | – | 1.5 | – | 0.4 | – | -0.3 | -0.3 | -0.4 | -0.4 | – | -0.3 | -29 | – | 24 | -219 | 41 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | |
| – | -0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | 0.0 | -0.1 | |
| -0.3 | -0.3 | 3.0 | 3.0 | 3.1 | 3.1 | 3.3 | 3.3 | 23 | 23 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 7.4 | 7.4 | 1.0 | 1.0 | 65 | 65 | 0.1 | 0.1 | 0.0 | 0.1 | 0.8 | 289 | 10 | |
| -1.3 | -1.3 | 0.4 | 0.4 | 0.6 | 0.6 | 0.2 | 0.2 | 4.8 | 4.8 | -2.5 | -2.5 | 4.9 | 4.9 | -4.2 | -4.2 | -3.3 | 2.7 | 2.7 | -2.9 | -2.9 | 61 | 61 | -7.9 | -7.9 | -7.9 | 0.2 | -12 | 52 | -31 | |
| -2.7 | -2.7 | -2.6 | -2.6 | -2.5 | -2.5 | -3.1 | -3.1 | -3.3 | -3.3 | -3.7 | -3.7 | -4.4 | -4.4 | -6.3 | -6.3 | -6.0 | -5.5 | -5.5 | -3.9 | -3.9 | -3.2 | -3.2 | -8.0 | -8.0 | -11 | -12 | -38 | -73 | -95 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.